On March 5, 2024, the Federal Trade Commission (“the FTC”) hosted a public workshop titled “Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care”, which covered the impact of private equity investment on the health care system. The workshop included panelists from the FTC, the Department of Justice (“the DOJ”), the Department of Health and Human Services (“HHS”) (together, “the Agencies”), academic thought-leaders, and health care professionals. On the same day as the workshop the Agencies launched a “Cross-Government Inquiry on Impact of Corporate Greed in Health Care,” issuing a Request for Information (“RFI”) seeking public comment on health care deals involving private equity firms, including deals that would not be reportable under the Hart-Scott-Rodino Act. The Agencies will use the RFI to inform future enforcement and policy decisions related to health care consolidation. The public has 60 days to submit comments to the Agencies.
Latest Post
More Posts
Webinar: Navigating Increased Scrutiny for Health Care Deals in 2024
The Wait is Over: DOJ and FTC Issue Final Merger Guidelines
FTC, DOJ, and HHS Announce Interagency Initiatives to Promote Healthcare Competition
DOJ Announces Mergers & Acquisitions Safe Harbor Policy
Mergers & Acquisitions Update: A Closer Look at the Impact of the FTC and DOJ’s Proposed HSR Act Filing Reform on Private Equity Firms
FTC Sues Private Equity Firm and Anesthesiology Practice for Antitrust Violations
AI Under the Antitrust Microscope: Competition Enforcers Focusing on Generative AI from All Angles
A Big Deal: FTC and DOJ Issue Long-Awaited New Draft Merger Guidelines
Notice of Proposed Rulemaking: FTC Proposes to Redesign and Dramatically Expand the Scope of the HSR Act Filing Process
Subscribe: Subscribe via RSS